Several key drivers are propelling the Clinical Trials Market, including clinical trials in emerging markets, pharmaceutical industry R&D expenditure, disease prevalence, rare diseases, and orphan drug research in the pipeline. The market is increasing due to several causes such as more diseases that require advanced and stronger medicines for both diagnosis and treatment. For example, according to the IDF Diabetes Atlas (2025), 11.1%, i.e., about 1 in 9 people of the adult population between 20 and 79 years is living with diabetes. This kind of disease burden is increasingly burdening the Clinical Trials Market.
Global Clinical Trials market size was valued at USD 79.58 Billion in 2023 and is poised to grow from USD 84.57 Billion in 2024 to USD 140.27 Billion by 2032, growing at a CAGR of 6.50% in the forecast period (2025-2032).
Moreover, the industry is witnessing expansion from government activities in various regions. The NIH’s National Cancer Institute launched the Virtual Clinical Trials Office in February 2024. The agency did this to combat the declining environment of cancer trial enrollment by providing centralized remote staffing support to trial sites. This will be especially effective for the rural and underserved areas. Governmental support and this kind of initiative is helping industries grow and expand globally.
Get a Free Sample PDF of the Report – https://www.skyquestt.com/sample-request/clinical-trials-market
Clinical Trials Market – Regional Analysis:
The North America clinical trials market emerges as the most dominant clinical trials market in the world. The region’s importance can be attributed to the increase in R&D funds coupled with an increased adoption of modern technology in clinical trials. Companies such as Thermo Fisher Scientific, IQVIA, Laboratory Corporation of America Holdings, Syneos Health and many more headquartered in the region are leading the marketspace. The United States emerges as the hub for clinical trials sales in the region.
In North America, U.S. leads the clinical trials market especially due to its strong regulatory framework, significant R&D investments, and a dense concentration of pharmaceutical and biotech companies. The presence of a federal agency like FDA that has streamlined approval pathways and promoted innovation has enabled rapid adoption of decentralized trials, AI, and real-world data. The clinical research infrastructure of the country is also very extensive. In May 2025, the U.S. FDA granted accelerated approval to AbbVie’s EMRELIS™ (telisotuzumab vedotin-tllv). It is the first targeted ADC therapy for advanced NSCLC patients with high c-Met protein overexpression. This highlights how strong the US’ clinical trials market is.
Detailed Segmentation and Classification of the report (Market Size and Forecast – 2032, Y-o-Y growth rate, and CAGR):
The Clinical Trials Market can be segmented based on several factors, including product type, application, end-user, and distribution channel.
The global clinical trials market is segmented into service type, phase, modality, therapeutic area, delivery model, study design, end user, and region.
By service type, the market is classified into clinical trial management & monitoring, laboratory services (analytical testing services, bioanalytical testing services), clinical trial data management services, clinical trial supply & logistic services, consulting, patient recruitment & retention, medical writing, safety & pharmacovigilance, and others.
Depending on phase, it is divided into Phase I, Phase II, Phase III, and Phase IV.
By modality, the market is classified into small molecules, biologics, and medical devices & IVD.
According to therapeutic area, the market is categorized into oncology, neurology, psychiatry, respiratory disorders, cardiovascular diseases, metabolic disorders, endocrinology, dermatology, gastrointestinal diseases, immunological disorders, infectious diseases, hematology, ophthalmology, urology & genitourinary disorders, women’s health, and others.
By delivery model, the market is classified into Full-Service Outsourcing (FSO) model, Functional Service Provider (FSP) model, and hybrid model.
Depending on study design, it is divided into interventional, and observational.
By end user, the market is classified into pharmaceutical & biopharmaceutical companies, medical device companies, and academic institutes.
Regionally, the market is analyzed across North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
Top Market Players in Clinical Trials Market are:
Thermo Fisher Scientific, Inc. (US)
IQVIA, Inc. (US)
ICON plc (Ireland)
Laboratory Corporation of America Holdings (US)
Syneos Health (US)
WuXi AppTec (China)
Charles River Laboratories (US)
EQT Private Equity (Parexel International Corporation) (US)
Medpace (US)
SGS (Switzerland)
Frontage Labs (US)
ACM Global Laboratories (US)
Kohlberg & Company (Worldwide Clinical Trials) (US)
Guires (Pepgra) (India)
CTI Clinical Trial and Consulting Services (US)
Dove Quality Solutions (UK)
Firma Clinical Research (US)
H.I.G. Capital (Celerion) (US)
Novotech (Australia)
Linical Group (Japan)
Recent Developments in Clinical Trials
In March 2025, Mural Health and ICON plc partnered with each other to improve the clinical trial participant and site experiences using Mural Link. Mural Link is a platform which has payment, tax, travel, communication, and analytics tools. The collaboration will help to reduce participation barriers and administrative burden. This, in turn, will lead to more inclusive recruitment and better retention. ICON will use Mural Health’s fee-free debit card option and services to improve its patient support and trial efficiency in clinical research operations.
Cinven sold a minority stake in SYNLAB to Labcorp, in March 2025. SYNLAB is a provider of diagnostic services across 30+ countries. The transaction was done to explore collaborations in specialty testing, clinical trials, procurement, and personalized care, with Labcorp joining SYNLAB’s holding company board alongside Cinven and other co-investors.
You may Also Like
https://sites.google.com/view/insightdigits/cyber-insurance-market
https://skyquesttmarket.wordpress.com/2025/05/09/cyber-insurance-market-growing-demand-amid-rising-cyber-threats/
Forward-Looking Insights
The Clinical Trials Market is set to experience sustained growth, fueled by technological advancements, broader global market access, and rising industry demand. With the industry addressing emerging challenges and capitalizing on new opportunities, it is expected to drive innovation and play a pivotal role in advancing global health and economic progress.
About Company:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.
Contact Details:
SkyQuest Technology Group
USA (+1) 351-333-4748
Email: [email protected]”””
